第40届摩根大通医疗保健年会。虚拟——2022年1月10日至13日

IF 0.2 4区医学 Q4 Medicine Drugs of The Future Pub Date : 2022-01-01 DOI:10.1358/dof.2022.47.4.3422311

P. Sudha, J. Polychrones, D. Komlos

{"title":"第40届摩根大通医疗保健年会。虚拟——2022年1月10日至13日","authors":"P. Sudha, J. Polychrones, D. Komlos","doi":"10.1358/dof.2022.47.4.3422311","DOIUrl":null,"url":null,"abstract":"The 40th Annual J.P. Morgan Healthcare Conference was conducted as a virtual conference for the second consecutive year due to the COVID-19 pandemic. Being the largest investment symposium in the healthcare industry, the conference brought together thousands of investors around the globe and hundreds of companies from the whole global healthcare landscape, that includes pharmaceutical companies, medical device firms, healthcare service providers, and profit and not-for-profit organizations. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2022 Clarivate","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The 40th Annual J.P. Morgan Healthcare Conference. Virtual - January 10-13, 2022\",\"authors\":\"P. Sudha, J. Polychrones, D. Komlos\",\"doi\":\"10.1358/dof.2022.47.4.3422311\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The 40th Annual J.P. Morgan Healthcare Conference was conducted as a virtual conference for the second consecutive year due to the COVID-19 pandemic. Being the largest investment symposium in the healthcare industry, the conference brought together thousands of investors around the globe and hundreds of companies from the whole global healthcare landscape, that includes pharmaceutical companies, medical device firms, healthcare service providers, and profit and not-for-profit organizations. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2022 Clarivate\",\"PeriodicalId\":11366,\"journal\":{\"name\":\"Drugs of The Future\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs of The Future\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1358/dof.2022.47.4.3422311\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.4.3422311","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The 40th Annual J.P. Morgan Healthcare Conference. Virtual - January 10-13, 2022

The 40th Annual J.P. Morgan Healthcare Conference was conducted as a virtual conference for the second consecutive year due to the COVID-19 pandemic. Being the largest investment symposium in the healthcare industry, the conference brought together thousands of investors around the globe and hundreds of companies from the whole global healthcare landscape, that includes pharmaceutical companies, medical device firms, healthcare service providers, and profit and not-for-profit organizations. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2022 Clarivate

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Drugs of The Future 医学-药学

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions. The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.